← Leaderboards
Celso Enrique Gomez-Sanchez
G V Sonny Montgomery Va Medcial Center
$11,944,926
Attributed
$11,944,926
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,944,926 · 8
VA$0 · 1
By mechanism
U54$6,102,563 · 3
R01$5,222,244 · 2
R21$512,625 · 2
R03$107,494 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Aldosterone”
- Gordon H Williams · Harvard University (Medical School)$19,134,930
- John C Burnett · Mayo Clinic Coll Of Medicine, Rochester$16,689,598
- William E Rainey · University Of Texas Sw Med Ctr/Dallas$13,557,652
- Iris Z Jaffe · Tufts Medical Center$12,229,603
- Anand Vaidya · Brigham And Women'S Hospital$12,198,982
- Gail Kurr Adler · Brigham And Women'S Hospital$11,791,898
Research focus
AldosteroneRegulationHypertensionAdrenal GlandsHyperaldosteronismMineralocorticoidsBlood PressureKidneyEnzymesCardiovascular SystemProductionAreaCellsAngiotensin IiEssential HypertensionInterestAffectAnabolismPlayCell LineMineralocorticoid ReceptorSecondary HypertensionAdenomaCerebrovascular
Grant awards (41)
Pilot Projects Program$622,566
U54 · FY2025 · GM · contact PI
Pilot Projects Program$747,121
U54 · FY2024 · GM · contact PI
Pilot Projects Program$747,085
U54 · FY2023 · GM · contact PI
Regulation of Mineralocorticoid Receptor Action$0
I01 · FY2023 · VA · contact PI
Pilot Projects Program$762,519
U54 · FY2022 · GM · contact PI
Adrenal cell ATP1A1 mutations and mechanisms of aldosterone biosynthesis$318,750
R01 · FY2022 · HL · contact PI
Regulation of Mineralocorticoid Receptor Action$0
I01 · FY2022 · VA · contact PI
Pilot Projects Program$397,798
U54 · FY2021 · GM · contact PI
Adrenal cell ATP1A1 mutations and mechanisms of aldosterone biosynthesis$318,750
R01 · FY2021 · HL · contact PI
Regulation of Mineralocorticoid Receptor Action$0
I01 · FY2021 · VA · contact PI
Regulation of Mineralocorticoid Receptor Action$0
I01 · FY2021 · VA · contact PI
Pilot Projects Program$598,920
U54 · FY2020 · GM · contact PI
Adrenal cell ATP1A1 mutations and mechanisms of aldosterone biosynthesis$318,750
R01 · FY2020 · HL · contact PI
Pilot Projects Program$598,920
U54 · FY2019 · GM · contact PI
Adrenal cell ATP1A1 mutations and mechanisms of aldosterone biosynthesis$318,750
R01 · FY2019 · HL · contact PI
Pilot Projects Program$551,792
U54 · FY2018 · GM · contact PI
Pilot Projects Program$598,921
U54 · FY2017 · GM · contact PI
Role of Mineralocorticoids in Hypertension$286,875
R01 · FY2017 · HL · contact PI
Pilot Projects Program$476,921
U54 · FY2016 · GM · contact PI
Role of Mineralocorticoids in Hypertension$286,875
R01 · FY2016 · HL · contact PI
Role of Mineralocorticoids in Hypertension$282,571
R01 · FY2015 · HL · contact PI
Role of Mineralocorticoids in Hypertension$286,875
R01 · FY2014 · HL · contact PI
Role of Mineralocorticoids in Hypertension$250,470
R01 · FY2012 · HL · contact PI
Regulation of the late-pathway of aldosterone biosynthesis$191,250
R21 · FY2012 · HL · contact PI
Role of Mineralocorticoids in Hypertension$253,000
R01 · FY2011 · HL · contact PI
Regulation of the late-pathway of aldosterone biosynthesis$159,375
R21 · FY2011 · HL · contact PI
Role of Mineralocorticoids in Hypertension$253,000
R01 · FY2010 · HL · contact PI
Role of Mineralocorticoids in Hypertension$303,000
R01 · FY2009 · HL · contact PI
Chaperones, immunophilins and nuclear receptor shuttling$33,748
R03 · FY2009 · TW · contact PI
Chaperones, immunophilins and nuclear receptor shuttling$33,748
R03 · FY2008 · TW · contact PI
Role of Mineralocorticoids in Hypertension$92,663
R01 · FY2007 · HL · contact PI
Chaperones, immunophilins and nuclear receptor shuttling$39,998
R03 · FY2007 · TW · contact PI
Role of Mineralocorticoids in Hypertension$252,914
R01 · FY2006 · HL · contact PI
Role of Mineralocorticoids in Hypertension$259,000
R01 · FY2005 · HL
Role of Mineralocorticoids in Hypertension$259,000
R01 · FY2004 · HL
DDR1 controls tumor homing in breast to bone metastasis$81,000
R21 · FY2004 · CA
MINERALOCORTICOIDS AND HYPERTENSION$228,541
R01 · FY2003 · HL
DDR1 controls tumor homing in breast to bone metastasis$81,000
R21 · FY2003 · CA
MINERALOCORTICOIDS AND HYPERTENSION$222,905
R01 · FY2002 · HL
MINERALOCORTICOIDS AND HYPERTENSION$217,434
R01 · FY2001 · HL
MINERALOCORTICOIDS AND HYPERTENSION$212,121
R01 · FY2000 · HL